Focus Partners Advisor Solutions LLC Acquires 4,707 Shares of Veeva Systems Inc. $VEEV

Focus Partners Advisor Solutions LLC boosted its holdings in Veeva Systems Inc. (NYSE:VEEV) by 423.3% during the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 5,819 shares of the technology company’s stock after acquiring an additional 4,707 shares during the quarter. Focus Partners Advisor Solutions LLC’s holdings in Veeva Systems were worth $1,675,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also added to or reduced their stakes in the business. Vanguard Group Inc. increased its stake in Veeva Systems by 2.2% in the first quarter. Vanguard Group Inc. now owns 14,760,566 shares of the technology company’s stock valued at $3,418,990,000 after acquiring an additional 315,421 shares during the period. Alliancebernstein L.P. grew its stake in Veeva Systems by 10.7% during the first quarter. Alliancebernstein L.P. now owns 5,499,651 shares of the technology company’s stock worth $1,273,884,000 after buying an additional 532,269 shares during the last quarter. T. Rowe Price Investment Management Inc. grew its stake in Veeva Systems by 0.7% during the first quarter. T. Rowe Price Investment Management Inc. now owns 5,203,867 shares of the technology company’s stock worth $1,205,372,000 after buying an additional 34,169 shares during the last quarter. Price T Rowe Associates Inc. MD grew its stake in Veeva Systems by 20.9% during the first quarter. Price T Rowe Associates Inc. MD now owns 3,992,372 shares of the technology company’s stock worth $924,754,000 after buying an additional 689,700 shares during the last quarter. Finally, JPMorgan Chase & Co. grew its stake in Veeva Systems by 7.5% during the first quarter. JPMorgan Chase & Co. now owns 3,230,758 shares of the technology company’s stock worth $748,341,000 after buying an additional 225,125 shares during the last quarter. Institutional investors own 88.20% of the company’s stock.

Insider Buying and Selling at Veeva Systems

In other Veeva Systems news, SVP Jonathan Faddis sold 14,595 shares of the firm’s stock in a transaction that occurred on Thursday, October 2nd. The shares were sold at an average price of $300.00, for a total value of $4,378,500.00. Following the transaction, the senior vice president directly owned 8,588 shares of the company’s stock, valued at approximately $2,576,400. This trade represents a 62.96% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Eleni Nitsa Zuppas sold 6,000 shares of the firm’s stock in a transaction that occurred on Tuesday, October 7th. The shares were sold at an average price of $306.62, for a total transaction of $1,839,720.00. Following the completion of the transaction, the insider directly owned 25,325 shares in the company, valued at approximately $7,765,151.50. The trade was a 19.15% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 24,665 shares of company stock valued at $7,438,000. 10.30% of the stock is currently owned by insiders.

Wall Street Analysts Forecast Growth

Several analysts have weighed in on VEEV shares. Piper Sandler upped their price objective on shares of Veeva Systems from $325.00 to $355.00 and gave the stock an “overweight” rating in a research note on Thursday, August 28th. TD Cowen raised shares of Veeva Systems from a “hold” rating to a “buy” rating and upped their price objective for the stock from $297.00 to $380.00 in a research note on Tuesday, October 7th. KeyCorp upped their price objective on shares of Veeva Systems from $285.00 to $325.00 and gave the stock an “overweight” rating in a research note on Monday, July 14th. Stifel Nicolaus upped their price objective on shares of Veeva Systems from $295.00 to $320.00 and gave the stock a “buy” rating in a research note on Thursday, August 28th. Finally, Mizuho upped their price objective on shares of Veeva Systems from $295.00 to $325.00 and gave the stock an “outperform” rating in a research note on Friday, August 29th. Seventeen equities research analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and two have assigned a Sell rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $307.58.

Veeva Systems Trading Up 0.6%

Shares of VEEV stock opened at $293.11 on Monday. Veeva Systems Inc. has a 1 year low of $201.54 and a 1 year high of $310.50. The firm’s 50 day moving average is $284.70 and its 200-day moving average is $270.03. The firm has a market capitalization of $48.04 billion, a price-to-earnings ratio of 60.19, a PEG ratio of 2.26 and a beta of 0.98.

Veeva Systems (NYSE:VEEV) last announced its earnings results on Wednesday, August 27th. The technology company reported $1.26 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.90 by ($0.64). Veeva Systems had a return on equity of 13.72% and a net margin of 27.29%.The company had revenue of $789.08 million for the quarter, compared to analyst estimates of $768.49 million. During the same quarter in the previous year, the company posted $1.62 earnings per share. Veeva Systems’s revenue for the quarter was up 16.7% on a year-over-year basis. Veeva Systems has set its Q3 2026 guidance at 1.940-1.950 EPS. FY 2026 guidance at 7.780-7.780 EPS. On average, equities research analysts forecast that Veeva Systems Inc. will post 4.35 earnings per share for the current fiscal year.

Veeva Systems Company Profile

Veeva Systems Inc provides cloud-based software for the life sciences industry. It offers Veeva Commercial Cloud, a suite of software and analytics solutions, such as Veeva customer relationship management (CRM) that enable customer-facing employees at pharmaceutical and biotechnology companies; Veeva Vault PromoMats, an end-to-end content and digital asset management solution; Veeva Vault Medical that provides source of medical content across multiple channels and geographies; Veeva Crossix, an analytics platform for pharmaceutical brands; Veeva OpenData, a customer reference data solution; Veeva Link, a data application that allows link to generate real-time intelligence; and Veeva Compass includes de-identified and longitudinal patient data for the United States.